Alyeska Investment Group’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-140,000	Closed	-$1.84M	–	514
2016 Q4	$1.84M	Buy	140,000 +105,000	+300%	+$1.38M	0.02%	381
2016 Q3	$596K	Buy	+35,000	New	+$596K	0.01%	414